Celadon Pharmaceuticals
Celadon Pharmaceuticals · page 2
- Markets & Stocks
Hellenic Dynamics Sees Stocks Slide On News It Will No Longer Target EU-GMP, DeepVerge Downsizes Core Operations, & Celadon Publishes 2022 Figures
Hellenic Dynamics [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HELD.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Hellenic Dynamics has seen its stock drop nearly 40% this week following an announcement that it would no longer be pursuing EU GMP (Good Manufacturing Practice) certification for its facility.
- Markets & Stocks
Chill Brands Sees Stock Climb 80% On New UK Supply Deal, IM Cannabis Reduces Losses, & Celadon Signs First Supply Contract
Chill Brands Group [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CHLL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Chill Brands’ stock value has nearly doubled over the last week following the announcement of a new sales and distribution partnership in the UK.
- Medical
UK Holds First Ever Debate On ‘Economic Contribution Of Medical Cannabis’
Yesterday the first-ever parliamentary debate on the UK’s rapidly growing medical cannabis industry took place in Westminster Hall, focusing on the ‘economic contribution of medical cannabis’ in the UK.
- Press releases
MGC Pharmaceuticals Has Completed The Pre-Clinical Study On CimetrA™, Exploring The Mechanism Of Action (MoA) Of The Product
PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of breakthrough cannabis-based medicines, announces that its current Home Office licence has been successfully updated to allow the commercial sale of its high Δ9-tetrahydrocannabinol (“THC”) product, following the Company’s…
- Pharmaceutical
UK’s Medical Cannabis Industry Enjoys Strong Start To 2023
LAST week a flurry of positive announcements from across the UK’s medical cannabis industry were unveiled in signs the industry is wasting no time in shaking off the stagnation of 2022.
- Pharmaceutical
European Cannabis Stocks Review: Celadon Shares Jump After Regulatory Win, IM Cannabis Closes Private Placement, & More From SEED
IM Cannabis IM Cannabis saw its stock price jump by nearly 10% this week after it announced the receipt of US$500k in funding in a private placement led by two company insiders.
- Medical
MHRA’s New Guidance Points To A ‘Truly Pharmaceutical Path’ For UK Medical Cannabis And Could See End To ‘GACP To GMP Washing’
THE UK’s Medicines and Healthcare products Regulatory Agency (MHRA) last week released new detailed guidelines for medical cannabis companies operating in the UK.
- Adult-Use
European Cannabis Stocks Review: Hellenic Dynamics & Cantourage Both Set To Go Public In Coming Months
Hellenic Dynamics Greek medical cannabis cultivator Hellenic Dynamics is reportedly poised to become the first company of its kind to list on the London Stock Exchange (LSE), nearly 18 months since it first announced its intention to go public.
- Pharmaceutical
Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses
AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies released their latest financial figures.
- Pharmaceutical
Celadon Becomes First UK Cannabis Company To Be Admitted To AIM In 21 Years
CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years.
